Ligand Pharmaceuticals
LGND
LGND
187 hedge funds and large institutions have $1.73B invested in Ligand Pharmaceuticals in 2015 Q1 according to their latest regulatory filings, with 37 funds opening new positions, 63 increasing their positions, 61 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
3% more repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 61
3% less call options, than puts
Call options by funds: $8.29M | Put options by funds: $8.53M
Holders
187
Holding in Top 10
10
Calls
$8.29M
Puts
$8.53M
Top Buyers
| 1 | +$34.8M | |
| 2 | +$22.7M | |
| 3 | +$18.8M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$15.8M |
| 5 |
Bank of New York Mellon
New York
|
+$13.3M |
Top Sellers
| 1 | -$45.7M | |
| 2 | -$18.7M | |
| 3 | -$14.1M | |
| 4 |
BC
Broadfin Capital
New York
|
-$10.6M |
| 5 |
RCMC
RK Capital Management (Colorado)
Denver,
Colorado
|
-$10.1M |